C1 esterase inhibitor (human) Pregnancy and Breastfeeding Warnings
Brand names: Berinert, Cinryze, Haegarda
Medically reviewed by Drugs.com. Last updated on Nov 16, 2023.
C1 esterase inhibitor (human) Pregnancy Warnings
FDA pregnancy category: C
Use only if clearly needed and benefit outweighs potential risk.
Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.
C1 esterase inhibitor (human) Breastfeeding Warnings
Caution is recommended
Excreted into human milk: Unknown
Excreted into animal milk: Unknown
The effects in the nursing infant are unknown.
See also
References for pregnancy information
- (2022) "Product Information. Cinryze (C1 esterase inhibitor, human)." ViroPharma Incorporated
References for breastfeeding information
- (2022) "Product Information. Cinryze (C1 esterase inhibitor, human)." ViroPharma Incorporated
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
